Replies to post #99993 on Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Very riveting Conference call: I was the one who asked the questions about MANF related to Diabetes I, the status of the Parkinsons program, Toxicology data results and the future Uplisting expectations.

Golden nugget: We moved to Janssen labs due to the primary interest in PhenoGuard (among other things). Dr. Commissiong to present at upcoming UK conference on status of PhenoGuard next week (very interesting development occuring there).

Btw: RISK did a great job with the Lympro questions too.